An expression signature of estrogen-regulated genes predicts disease-free survival in tamoxifen-treated patients better than progesterone receptor status.

Transactions of the American Clinical and Climatological Association

Volumn 119, Issue , 2008, Pages

  Lippman, Marc E ^a   Rae, James M ^a   Chinnaiyan, Arul M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR; RNA; TAMOXIFEN;

ARTICLE; BREAST TUMOR; DISEASE FREE SURVIVAL; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC DATABASE; GENETICS; HUMAN; METABOLISM; PROGNOSIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; DATABASES, GENETIC; DISEASE-FREE SURVIVAL; ESTRADIOL; ESTROGENS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; RNA, NEOPLASM; TAMOXIFEN;

EID: 55949086946     PISSN: 00657778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)